Lundbeck-backed Iconic Therapeutics, which aims to apply tissue factor biology to retinal disease and cancer treatments, has now raised $80m altogether.

IDG Capital-backed Testin has developed a cloud-based platform that lets developers test their mobile apps before releasing them.

The GV-backed round was closed at a reported $500m valuation, and brings the online lender's total debt and equity financing to just short of $260m.

IDG Capital Partners has returned to back a series C round for Daling that will help the mobile e-commerce company improve customer experience.

Cancer care technology developer Avelas has now raised about $35m altogether, after Pharmstandard led a series C round also featuring Alexandria and WuXi PharmaTech.

The China-based fitness app has followed a $32m Bertelsmann-backed round in May with more funding led by Tencent.

The game livestreaming platform raised the cash in a round co-led by strategic partner Tencent, the investor that co-led its $100m series B just five months ago.

The phone fraud prevention company has increased the size of the round, already featuring Google Capital, GV and Citi Ventures, to $80.8m.

The grid control technology producer has closed a round that had reached $13m in November, and which had been expected to reach $20m.